Sunday, March 15, 2026
ISSN 2765-8767
  • Home
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Home
  • Courses
  • About Us
  • Contact us
  • Support Us

India’s pandemic surge turns political

Outside an upscale Indian hospital last week, Baljeet Asthana put her phone on selfie mode, propped her eyeglasses on her head so she could stare directly into the camera, and hit record.

Through a white polka-dot mask, she described her family’s ordeal: Her 82-year-old mother was inside the hospital “struggling for her life,” Asthana said. Her mother desperately needed an intensive care unit bed, but the hospital — Fortis Hospital, one of the best-equipped private facilities in the capital, New Delhi — was full. Officials told the family to look for an ICU bed elsewhere.

“My mother is slowly dying,” reads her tweet accompanying her video.

Source: NPR

Daily Remedy

Daily Remedy

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Videos

2027 Medicare Advantage & Part D Advance Notice

GLP-1 Drugs Have Moved Past Weight Loss. Medicine Has Not Fully Caught Up.

Glucagon-Like Peptide–Based Therapies and Longevity: Clinical Implications from Emerging Evidence

Glucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...

Read more

Join Our Newsletter!